Investor Overview
AFFY (Common Stock)
Exchange Nasdaq CM
Price 1.40
Change(%) 3.448%
Volume 4,912,000
Data as of 05/22/13 4:05 PM ET Minimum 20 minute delay
Corporate Profile
Affymax, Inc. is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions. Our vision is to become a leader in the nephrology and specialty care space by delivering innovative therapeutic offerings to patients and healthcare providers.
Recent Releases
- Apr 2, 2013 Affymax Reports Fourth Quarter and Year-End 2012 Financial Results
- Mar 18, 2013 Affymax Announces Reduction in Force to Align Resources Around Ongoing Product Investigation
Transfer Agent
Computershare Trust Company, Inc.
350 Indiana Street, Suite 800, Golden, Colorado 80401
(800) 962-4284
